BACKGROUND AND OBJECTIVES: Associations of insurance coverage and source of care with use of human immunodeficiency virus (HIV)-related health, mental health, and substance abuse services are examined in a large, diverse, highly active antiretroviral therapy-era cohort. METHODS: Adults who were infected with HIV (n = 3818) were interviewed in clinics and community agencies in Los Angeles, Milwaukee, New York, and San Francisco regarding drug use behaviors, health status, and health care utilization. RESULTS: Most participants were insured by Medicaid. During the previous 3 months, 90% of privately insured, 87% of publicly insured, and 78% of uninsured participants had visited any provider. Publicly and privately insured participants were similar in receipt of antiretrovirals, prophylaxis against Pneumocystis carinii pneumonia, substance abuse services, and antidepressants. Uninsured participants were less likely to receive antiretrovirals but were more likely to use substance abuse services. Participants with no usual source of care were less likely to receive PCP prophylaxis. CONCLUSIONS: A lack of insurance is associated with barriers to care, but the advantage of private over public coverage appears smaller than in previous studies. PCP prophylaxis, substance abuse treatment, and antidepressants remain markedly underutilized. Educational initiatives about these treatments targeting providers and patients are indicated.
BACKGROUND AND OBJECTIVES: Associations of insurance coverage and source of care with use of human immunodeficiency virus (HIV)-related health, mental health, and substance abuse services are examined in a large, diverse, highly active antiretroviral therapy-era cohort. METHODS: Adults who were infected with HIV (n = 3818) were interviewed in clinics and community agencies in Los Angeles, Milwaukee, New York, and San Francisco regarding drug use behaviors, health status, and health care utilization. RESULTS: Most participants were insured by Medicaid. During the previous 3 months, 90% of privately insured, 87% of publicly insured, and 78% of uninsured participants had visited any provider. Publicly and privately insured participants were similar in receipt of antiretrovirals, prophylaxis against Pneumocystis carinii pneumonia, substance abuse services, and antidepressants. Uninsured participants were less likely to receive antiretrovirals but were more likely to use substance abuse services. Participants with no usual source of care were less likely to receive PCP prophylaxis. CONCLUSIONS: A lack of insurance is associated with barriers to care, but the advantage of private over public coverage appears smaller than in previous studies. PCP prophylaxis, substance abuse treatment, and antidepressants remain markedly underutilized. Educational initiatives about these treatments targeting providers and patients are indicated.
Authors: John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet Journal: J Subst Abuse Treat Date: 2011-06-22
Authors: Amy R Knowlton; Julia H Arnsten; Lois J Eldred; James D Wilkinson; Starley B Shade; Amy S Bohnert; Cui Yang; Lawrence S Wissow; David W Purcell Journal: AIDS Patient Care STDS Date: 2010-07 Impact factor: 5.078
Authors: Brigit Hatch; Miguel Marino; Marie Killerby; Heather Angier; Megan Hoopes; Steffani R Bailey; John Heintzman; Jean P O'Malley; Jennifer E DeVoe Journal: J Gen Intern Med Date: 2017-04-03 Impact factor: 5.128
Authors: Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust Journal: Am J Public Health Date: 2007-08-29 Impact factor: 9.308
Authors: Erica S Spatz; Sameer D Sheth; Kensey L Gosch; Mayur M Desai; John A Spertus; Harlan M Krumholz; Joseph S Ross Journal: J Gen Intern Med Date: 2014-02-20 Impact factor: 5.128
Authors: Adrian Liau; Nicole Crepaz; Cynthia M Lyles; Darrel H Higa; Mary M Mullins; Julia DeLuca; Sarah Petters; Gary Marks Journal: AIDS Behav Date: 2013-07